lamotrigine
Generic: lamotrigine
Labeler: aurobindo pharma limitedDrug Facts
Product Profile
Brand Name
lamotrigine
Generic Name
lamotrigine
Labeler
aurobindo pharma limited
Dosage Form
TABLET
Routes
Active Ingredients
lamotrigine 150 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
65862-229
Product ID
65862-229_fa1b319e-3ee3-41e0-8986-7b42885935f9
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA078956
Listing Expiration
2026-12-31
Marketing Start
2009-01-27
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65862229
Hyphenated Format
65862-229
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lamotrigine (source: ndc)
Generic Name
lamotrigine (source: ndc)
Application Number
ANDA078956 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (65862-229-01)
- 60 TABLET in 1 BOTTLE (65862-229-60)
- 10 BLISTER PACK in 1 CARTON (65862-229-78) / 10 TABLET in 1 BLISTER PACK (65862-229-10)
- 1000 TABLET in 1 BOTTLE (65862-229-99)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "fa1b319e-3ee3-41e0-8986-7b42885935f9", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "upc": ["0365862228017", "0365862229014", "0365862230010", "0365862230782", "0365862227782", "0365862229786", "0365862227010", "0365862228789"], "unii": ["U3H27498KS"], "rxcui": ["198427", "198428", "198429", "282401"], "spl_set_id": ["a9a4309e-fe43-4a26-a30f-c6577d650336"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (65862-229-01)", "package_ndc": "65862-229-01", "marketing_start_date": "20090127"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (65862-229-60)", "package_ndc": "65862-229-60", "marketing_start_date": "20090127"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (65862-229-78) / 10 TABLET in 1 BLISTER PACK (65862-229-10)", "package_ndc": "65862-229-78", "marketing_start_date": "20090127"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (65862-229-99)", "package_ndc": "65862-229-99", "marketing_start_date": "20090127"}], "brand_name": "Lamotrigine", "product_id": "65862-229_fa1b319e-3ee3-41e0-8986-7b42885935f9", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "65862-229", "generic_name": "Lamotrigine", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "150 mg/1"}], "application_number": "ANDA078956", "marketing_category": "ANDA", "marketing_start_date": "20090127", "listing_expiration_date": "20261231"}